MD2850G2 - Method of inducing the medicamental abortion - Google Patents

Method of inducing the medicamental abortion

Info

Publication number
MD2850G2
MD2850G2 MDA20050046A MD20050046A MD2850G2 MD 2850 G2 MD2850 G2 MD 2850G2 MD A20050046 A MDA20050046 A MD A20050046A MD 20050046 A MD20050046 A MD 20050046A MD 2850 G2 MD2850 G2 MD 2850G2
Authority
MD
Moldova
Prior art keywords
medicamental
abortion
inducing
hours
administered
Prior art date
Application number
MDA20050046A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD2850F1 (en
Inventor
Валентин ФРИПТУ
Виктор ГИКАВЫЙ
Людмила ФРИПТУ
Михаил ТОДИРАШ
Екатерина СТРАТУ
Корина КАРДАНЮК
Original Assignee
Валентин ФРИПТУ
Виктор ГИКАВЫЙ
Людмила ФРИПТУ
Михаил ТОДИРАШ
Екатерина СТРАТУ
Корина КАРДАНЮК
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Валентин ФРИПТУ, Виктор ГИКАВЫЙ, Людмила ФРИПТУ, Михаил ТОДИРАШ, Екатерина СТРАТУ, Корина КАРДАНЮК filed Critical Валентин ФРИПТУ
Priority to MDA20050046A priority Critical patent/MD2850G2/en
Publication of MD2850F1 publication Critical patent/MD2850F1/en
Publication of MD2850G2 publication Critical patent/MD2850G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, in particular to obstetrics and gynecology and may be used for the interruption of early pregnancy, namely up to 56 days, associated with amenorrhea.Summary of the invention consists in that it is administered per os 200 mg of mifepriston, then after the expiry of 24…48 hours it is administered fourfold intravaginally, every 6 hours, for one suppository, containing 50 mg of S-ethyl isothiourone bromide (isoturone).
MDA20050046A 2005-02-18 2005-02-18 Method of inducing the medicamental abortion MD2850G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050046A MD2850G2 (en) 2005-02-18 2005-02-18 Method of inducing the medicamental abortion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050046A MD2850G2 (en) 2005-02-18 2005-02-18 Method of inducing the medicamental abortion

Publications (2)

Publication Number Publication Date
MD2850F1 MD2850F1 (en) 2005-09-30
MD2850G2 true MD2850G2 (en) 2006-07-31

Family

ID=35057541

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050046A MD2850G2 (en) 2005-02-18 2005-02-18 Method of inducing the medicamental abortion

Country Status (1)

Country Link
MD (1) MD2850G2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD215Z (en) * 2007-10-16 2010-12-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Capacitive storage charger
MD20070283A (en) * 2007-10-16 2009-07-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Process for charging current formation for a capacitive energy storage system
MD4073C1 (en) * 2008-11-06 2011-05-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Stabilized high-voltage converter
MD281Z (en) * 2009-10-23 2011-04-30 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Adjustable resonant voltage converter

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263B1 (en) * 1995-03-01 1995-08-31 Victor GHICAVII Remedy with antihypotensive action "isoturon"
MD1223B1 (en) * 1997-07-15 1999-05-31 Univ Nicolae Testemitanu Application of S-methyl isothiouronium dimethyl phosphate as a va-so-con-stric-tor compound and pharmaceutical preparation on base thereof
MD1431F1 (en) * 1998-01-16 2000-03-31 Univ Nicolae Testemitanu Antihypotensive remedies
MD2228F1 (en) * 2003-01-21 2003-08-31 Univ Nicolae Testemitanu Use of isothiouronic derivatives in the treatment and prophylaxis of intestinal atony
MD2323F1 (en) * 2003-06-23 2003-12-31 Univ Nicolae Testemitanu Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma
MD2491F1 (en) * 2004-02-10 2004-07-31 Victor GHICAVII Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263B1 (en) * 1995-03-01 1995-08-31 Victor GHICAVII Remedy with antihypotensive action "isoturon"
MD1223B1 (en) * 1997-07-15 1999-05-31 Univ Nicolae Testemitanu Application of S-methyl isothiouronium dimethyl phosphate as a va-so-con-stric-tor compound and pharmaceutical preparation on base thereof
MD1431F1 (en) * 1998-01-16 2000-03-31 Univ Nicolae Testemitanu Antihypotensive remedies
MD2228F1 (en) * 2003-01-21 2003-08-31 Univ Nicolae Testemitanu Use of isothiouronic derivatives in the treatment and prophylaxis of intestinal atony
MD2323F1 (en) * 2003-06-23 2003-12-31 Univ Nicolae Testemitanu Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma
MD2491F1 (en) * 2004-02-10 2004-07-31 Victor GHICAVII Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Schaff E., Fielding S., Westhoff C. Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy. Contraception. 2002 Oct; 66(4), p. 247-250 *

Also Published As

Publication number Publication date
MD2850F1 (en) 2005-09-30

Similar Documents

Publication Publication Date Title
Angioni et al. New trends of progestins treatment of endometriosis
TW200612919A (en) Lonidamine analogues and their use in male contraception and cancer treatment
EA201200377A8 (en) METHOD OF ORAL CONTRACEPTION IN WOMEN, METHOD OF MANAGING UNDESIRABLE BLEEDING AND INTENDED FOR USE IN THESE METHODS
CO5611162A2 (en) METHODS TO PREVENT REPRODUCTIVE DISEASES IN VACCINE LIVESTOCK
PE20060127A1 (en) DRUG DELIVERY SYSTEM CONSISTING OF POLYETHYLENE COPOLYMER VINYL ACETATE
BR0007360A (en) Controlled release composition
BRPI0617683A2 (en) process for preventive hormonal contraception according to the need and use of a transdermal patch
BR9509019A (en) Process for manufacturing pharmaceutical dosage units and tablet free of organic solvents
MD2850G2 (en) Method of inducing the medicamental abortion
CA2468748A1 (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
DE60207877D1 (en) MIXTURE CONTAINING PROCYANIDINE FOR THE REDUCTION OF APPETITE IN MAMMALS
Wang et al. Effect of Frozen Embryo Transfer and Progestin-primed Ovary Stimulation on IVF outcomes in women with high body mass index
BRPI0414386A (en) compound, methods of manufacturing the same, for treating or preventing a disease, for activating er function in a bone cell, for inhibiting er function in a cell, for inhibiting il-6 expression, for inhibiting growth of an er-expressing neoplastic cell, for prevention of spermatogenesis, for prevention of an adverse reproductive effect associated with exposure to a lack of natural or chemically environmental hormonal balance, and, composition
TW200621312A (en) Oral solid dosage forms containing a low dose of estradiol
Park et al. Gynecologic complication of chronic graft-versus-host disease: Vaginal obstruction
AR043013A1 (en) PHARMACEUTICAL COMPOSITION INTENDED FOR THE TREATMENT OF ENDOMETRIOSIS
HUP0203050A2 (en) Treating endometriosis or infertility, or improving fertility
Farajkhoda et al. Assessment of two emergency contraceptive regimens in Iran: levonorgestrel versus the Yuzpe
GB2407504A (en) Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections
BOARD Endometrial carbonic anhydrase after diethylstilbestrol as a postcoital antifertility agent
Mishra et al. Role of micronised progesterone in maintenance therapy following arrested preterm labor: a randomised controlled trial
Chakalova et al. Cancer burden of breast and gynecological cancers in Bulgaria: epidemiology and clinical aspects
Maree et al. Appendiceal perforation caused by an intrauterine contraceptive device: A case report
ATE470669T1 (en) D-(17ALPHA)-13-ETHYL-17HYDROXY-18,19-DINORPREGN 4-ENE-20-YNE-3-ONE IN THE FORM OF THE PURE 3E AND 3Z OXIMES AND THE PROCESS FOR PRODUCING THE MIXTURE OF THE ISOMERS AS WELL AS THE PURE ISOMERS
Guttmacher Oral contraception

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees